Hua Wu

SVP RESEARCH & PRODUCT DEV. · SAB BIOTHERAPEUTICS, INC. · CIK 0001889408

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Oct 2021

HOLDINGS NOW

4,653

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Hua Wu. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

SABS · 4,653 shares · as of Oct 22, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2021

FLOW · 5 buys / 0 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
SABS SAB BIOTHERAPEUTICS, INC.	PURCHASEGRANT Stock grant	14,540	—	—	14,540	Oct 22, 2021	Oct 26, 2021 ↗	View →
SABS SAB BIOTHERAPEUTICS, INC.	PURCHASEGRANT Stock grant	58,161	—	—	58,161	Oct 22, 2021	Oct 26, 2021 ↗	View →
SABS SAB BIOTHERAPEUTICS, INC.	PURCHASEGRANT Stock grant	6,979	—	—	6,979	Oct 22, 2021	Oct 26, 2021 ↗	View →
SABS SAB BIOTHERAPEUTICS, INC.	PURCHASEGRANT Stock grant	32,191	—	—	32,191	Oct 22, 2021	Oct 26, 2021 ↗	View →
SABS SAB BIOTHERAPEUTICS, INC.	PURCHASEGRANT Stock grant	4,653	—	—	4,653	Oct 22, 2021	Oct 26, 2021 ↗	View →

Other insiders · SABS

Loading peer insiders…

About this filer

CIK 0001889408

ROLE

SVP Research & Product Dev.

PRIMARY

SABS

COMPANIES

ACTIVE SINCE

Oct 2021

MARKETPEEL · /INSIDER/0001889408DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.